Modeling Potential Demand for Supply-Constrained Drugs: A New Hemophilia Drug at Bayer Biological Products.
- Published in:
- Operations Research, 2009, v. 57, n. 1, p. 19, doi. 10.1287/opre.1070.0506
- By:
- Publication type:
- Article
Works matching DE "BAYER Biological Products (Company)"
Results: 2
1
2
Not All Intravenous Immunoglobulins Are the Same: Appropriate Selection in Patients with Compromised Renal Function.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 2, p. 296, doi. 10.1592/phco.26.2.296
- By:
- Publication type:
- Article